BindingDB logo
myBDB logout

Your request to link to MMDB for ITGAV/ITGB5


MMDB Description
55315Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor Staurosporine
86690Human Cyclin-dependent Kinase 2
86691Human Cyclin-dependent Kinase 2 Phosphorylated on THR 160
11979Crystal Structure of the Human Cdk2 Kinase Complex With Cell Cycle-regulatory Protein Ckshs1
12188Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor Purvalanol B
14472The Structure of Cyclin-dependent Kinase 2 (Cdk2) in Complex With 4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline
13361Human Cyclin-dependent Kinase 2 Complexed With the Inhibitor Hymenialdisine
91067Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor Nu2058
91068Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor Nu6027
48841THR 160 Phosphorylated Cdk2-human Cyclin A3 Complex With the Inhibitor Indirubin-5-sulphonate Bound
14968Crystal Structure of Murine Gamma Herpesvirus Cyclin Complexed to Human Cyclin Dependent Kinase 2
5224Cyclin A-cyclin-dependent Kinase 2 Complex
16075Crystal Structure of Kinase Associated Phosphatase (Kap) in Complex With Phospho-cdk2
15423The Structure of Cyclin-dependent Kinase 2 (Cdk2) in Complex With an Oxindole Inhibitor
15424The Structure of Cdk2cyclin a in Complex With an Oxindole Inhibitor
17593Crystal Structure of Human Cyclin Dependent Kinase 2 (Cdk2) in Complex With the Inhibitor H717
18391Human Cyclin Dependent Kinase 2 Complexed With the Cdk4 Inhibitor
18392Human Cyclin Dependent Kinase 2 Complexed With the Cdk4 Inhibitor
18393Human Cyclin Dependent Kinase 2 Complexed With the Cdk4 Inhibitor
19416Pcdk2cyclin a in Complex With Mgadp, Nitrate and Peptide Substrate
72206Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 2-amino-6-(3'-methyl-2'-oxo)butoxypurine
91106Cdk2 in Complex With a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
23817Cdk2 in Complex With a Disubstituted 2, 4-bis Anilino Pyrimidine Cdk4 Inhibitor
91107Cdk2 in Complex With a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
91108Cdk2 in Complex With a Disubstituted 2, 4-bis Anilino Pyrimidine Cdk4 Inhibitor
23241Human Cyclin Dependent Protein Kinase 2 in Complex With the Inhibitor 2-amino-6-[(r)-pyrrolidino-5'-yl]methoxypurine
23242Human Cyclin Dependent Protein Kinase 2 in Complex With the Inhibitor 2-amino-6-[cyclohex-3-enyl]methoxypurine
20562Structure of Human Thr160-phospho Cdk2cyclin a Complexed With the Inhibitor Nu2058
20563Structure of Human Thr160-phospho Cdk2cyclin a Complexed With the Inhibitor Nu6094
20564Structure of Human Thr160-phospho Cdk2cyclin a Complexed With the Inhibitor Nu6086
20565Structure of Human Thr160-phospho Cdk2cyclin a Complexed With the Inhibitor Nu6102
21606Cdk2cyclin a in Complex With a 9 Residue Recruitment Peptide From E2F
21607Cdk2cyclin a in Complex With an 11-residue Recruitment Peptide From Retinoblastoma-associated Protein
21608Cdk2cyclin a in Complex With an 11-residue Recruitment Peptide From P53
21609Cdk2cyclin a in Complex With an 11-residue Recruitment Peptide From P27
21610Cdk2cyclin a in Complex With an 11-residue Recruitment Peptide From P107
56308Human Cyclin-dependent Kinase 2
56309Human Cyclin-dependent Kinase 2
5324Phosphorylated Cyclin-dependent Kinase-2 Bound to Cyclin a
49840P27(kip1)cyclin Acdk2 Complex
17097The Structure of Cyclin-dependent Kinase 2 (Cdk2) in Complex With 4-[(6-amino-4-pyrimidinyl) Amino]benzenesulfonamide
18308Crystal Structure of Human Cdk2 (Unphosphorylated) in Complex With Pkf049-365
19534Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h- Indol-3-ylidene)methyl]amino}benzenesulfonamide
19535Cyclin-dependent Kinase 2 (Cdk2) Complexed With N-methyl-{4- [2-(7-oxo-6,7-dihydro-8h-[1,3]thiazolo[5,4-e]indol-8- Ylidene)hydrazino]phenyl}methanesulfonamide
19536Cyclin-dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2- Dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5- (1,3-oxazol-5-yl)-1,3-dihydro-2h-indol-2-one
19537Cyclin-dependent Kinase 2 (Cdk2) Complexed With 4-{[(2-oxo- 1,2-dihydro-3h-indol-3-ylidene)methyl]amino}-n-(1,3- Thiazol-2-yl)benzenesulfonamide
19538Cyclin-dependent Kinase 2 (Cdk2) Complexed With 3-{[4- ({[amino(imino)methyl]aminosulfonyl)anilino]methylene}-2- Oxo-2,3-dihydro-1h-indole
23920Structure of Human Thr160-phospho Cdk2cyclin a Complexed With a 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- Aminopyrimidine Inhibitor
28467Structure of Human Thr160-phospho Cdk2cyclin a Complexed With a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
50636Imidazopyridines: a Potent and Selective Class of Cyclin- Dependent Kinase Inhibitors Identified Through Structure- Based Hybridisation
50637Imidazopyridines: a Potent and Selective Class of Cyclin- Dependent Kinase Inhibitors Identified Through Structure- Based Hybridisation
50639Imidazopyridines: a Potent and Selective Class of Cyclin- Dependent Kinase Inhibitors Identified Through Structure- Based Hybridisation
28468Structure of Human Thr160-phospho Cdk2cyclin a Complexed With a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
28469Structure of Human Thr160-phospho Cdk2cyclin a Complexed With a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
74114Cyclin a Binding Groove Inhibitor H-arg-arg-leu-ile-phe-nh2
74115Cyclin a Binding Groove Inhibitor Ac-arg-arg-leu-asn- (M-cl-phe)-nh2
73405Cyclin a Binding Groove Inhibitor H-cit-cit-leu-ile-(p-f-phe)-nh2
74116Cyclin a Binding Groove Inhibitor H-arg-arg-leu-asn-(p-f-phe)-nh2
24473The Structure of Cyclin Dependent Kinase 2 (Ckd2) With a Trisubstituted Naphthostyril Inhibitor
23597The Strucure of Phospho-cdk2cyclin a in Complex With the Inhibitor 4,5,6,7-tetrabromobenzotriazole (Tbs)
25687Crystal Structure of Human Cyclin-dependent Kinase 2 Complexed With a Nucleoside Inhibitor
23656The Crystal Structure of Ucn-01 in Complex With Phospho- Cdk2cyclin a
25698APO Structure of Human Cyclin-dependent Kinase 2
25700Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2- Ylamine
25701Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine
25702Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]- N'-hydroxyiminoformamide
25703Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor [4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]- (4-trifluoromethyl-phenyl)-amine
27269Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 3-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2- Ylamino]-phenol
27270Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor 4-[4-(4-methyl-2-methylamino-thiazol-5-yl)- Pyrimidin-2-ylamino]-phenol
27271Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor [4-(2-amino-4-methyl-thiazol-5-yl)-pyrimidin-2- Yl]-(3-nitro-phenyl)-amine
27272Human Cyclin Dependent Kinase 2 Complexed With the Inhibitor N-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]- N',n'-dimethyl-benzene-1,4-diamine
28501Crystal Structure of Cdk2 With Inhibitor
11811Phosphorylated Cdk2-cyclyin A-substrate Peptide Complex
26171Cdk2 Complex With a 4-alkynyl Oxindole Inhibitor
74367Cyclin a Binding Groove Inhibitor Ace-arg-lys-leu- Phe-gly
51705Cdk2 in Complex With an Imidazo[1,2-b]pyridazine
51756Cdk2 in Complex With a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
28447Structure of Cdk2cyclin a With Pnu-292137
28448Structure of Cdk2 Complexed With Pnu-181227
31343Crystals Structure of Human Cdk2 in Complex With the Inhibitor Olomoucine
51877Co-crystal Structure of 6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine and Monomeric Cdk2
31900The Structural Basis of Cdk2 Activation by Cyclin E
31391Screening for Fragment Binding by X-ray Crystallography
32043Crystal Structure of Human Cdk2 Complexed With a Pyrazolo[1, 5-a]pyrimidine Inhibitor
32044Crystal Structure of Human Cdk2 Complexed With a Pyrazolo[1, 5-a]pyrimidine Inhibitor
36955Crystal Structure of Cdk2 With an Aminoimidazo Pyridine Inhibitor
37020Human Cdk2 in Complex With Olomoucine II, a Novel 2,6,9- Trisubstituted Purine Cyclin-dependent Kinase Inhibitor
41297Human Cyclin-dependent Kinase 2 in Complex With Roscovitine
35692Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph- 042562
35693Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din- 234325
35694Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din- 232305
35695Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Indenopyraxole Din-101312
32662Human Cyclin Dependent Protein Kinase 2 in Complex With the Inhibitor 5-bromo-indirubine
32663Human Cyclin Dependent Protein Kinase 2 in Complex With the Inhibitor 4-hydroxypiperindinesulfonyl-indirubine
38056Structure of Cdk2-cyclin a With Pha-404611
36731Structure of Cdk2-cyclin a With Pha-630529
36215Structure of Cdk2 Complexed With Pnu-198873
36216Structure of Cdk2 Complexed With Pnu-230032
36260Structure of Cdk2-cyclin a With Pha-533514
38076Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
38077Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
86903Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
38081Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
38082Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
86905Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor
36760Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor
36761Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor
36762Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor
36763Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor
86907Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor
86908Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor
36766Crystal Structure of the Human Cdk2 Complexed With the Triazolopyrimidine Inhibitor
39101The Crystal Structure of Cdk2 Cyclin a in Complex With a Substrate Peptide Derived From CDC Modified With a Gamma- Linked ATP Analogue
39102Crystal Structure of Phospho-cdk2 Cyclin a in Complex With a Peptide Containing Both the Substrate and Recruitment Sites of Cdc6
38626Mechanism of CDK Inhibition by Active Site Phosphorylation: Cdk2 Y15p T160p in Complex With Cyclin a Structure
425814-arylazo-3,5-diamino-1h-pyrazole CDK Inhibitors: SAR Study, Crystal Structure in Complex With Cdk2, Selectivity, and Cellular Effects
46879Human Cyclin Dependent Kinase 2 Complexed With the Cdk4 Inhibitor
43718Structure of Cdk2 With a 3-hydroxychromones
36838Human Cdk2 in Complex With Isopentenyladenine
42189Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine Inhibitor
39347Structure of THR 160 Phosphorylated Cdk2cyclin a in Complex With the Inhibitor Nu6271
42325Cdk2cyclin a Complexed With a Thiophene Carboxamide Inhibitor
41817Structure of Human Thr160-phospho Cdk2-cyclin a Complexed With a Bisanilinopyrimidine Inhibitor
41818Structure of Human Thr160-phospho Cdk2-cyclin a F82h-l83v- H84d Mutant With an O6-cyclohexylmethylguanine Inhibitor
41819Structure of Human Thr160-phospho Cdk2-cyclin a Complexed With a Bisanilinopyrimidine Inhibitor
60474Crystal Structure of Cdk2 in Complex With Macrocyclic Aminopyrimidine
46324Crystal Structure of Phospho-cdk2 in Complex With Cyclin B
61984Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61985Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61986Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61987Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61988Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61989Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61990Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61991Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61992Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61993Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61994Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61995Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
61996Crystal Structure of Cyclin-dependent Kinase 2 With Inhibitor
66553Crystal Structure of a 3-aminoindazole Compound With Cdk2
45391Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
47311Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor
47312Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor
47313Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor
47315Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor
47316Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor
47317Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor
47319Crystal Structure of Human Cdk2 Complexed With a Thiazolidinone Inhibitor
62126Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
65828Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65829Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65830Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65831Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65832Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65833Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65834Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65835Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65836Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65837Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65838Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65839Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65840Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65841Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (At7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
65845Cdk2 in Complex With an Imidazole Piperazine
67301Structure of Cdk2 in Complex With an Imidazolyl Pyrimidine, Compound 5B
66860Structure of Cdk2 in Complex With an Imidazolyl Pyrimidine, Compound 5C
67710Cdk2 in Complex With the Imidazole Pyrimidine Amide, Compound (S)-8b
69247Fragment-based Discovery of the Pyrazol-4-yl Urea (At9283), a Multi-targeted Kinase Inhibitor With Potent Aurora Kinase Activity
82117Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a Through Structure Guided Design
73105Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a Through Structure Guided Design
73109Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a Through Structure Guided Design
75550Structure of Cdk2-cyclin a With Pha-848125
75551Structure of Cdk2-cyclin a Complexed With 8-anilino-1- Methyl-4,5-dihydro-1h-pyrazolo[4,3-h] Quinazoline-3- Carboxylic Acid
84494Structural and Thermodynamic Consequences of Cyclization of Peptide Ligands for the Recruitment Site of Cyclin a
84495Structural and Thermodynamic Consequences of Cyclization of Peptide Ligands for the Recruitment Site of Cyclin a
80223Optimisation of 6,6-dimethyl Pyrrolo 3,4-c Pyrazoles: Identification of Pha-793887, a Potent CDK Inhibitor Suitable for Intravenous Dosing
80229Structure of Cdk2-cyclin a With a Pyrazolo(4,3-h) Quinazoline-3-carboxamide Inhibitor
80073Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a Through Structure Guided Design
86033Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents
86035Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents
62420Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor Meriolin 3
62421Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor Meriolin 5
62422Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor Variolin B
65636Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor CR8
65637Structure of Phosphorylated Thr160 Cdk2cyclin a in Complex With the Inhibitor Roscovitine
67039Structure of THR 160 Phosphorylated Cdk2cyclin a in Complex With the Inhibitor N-&-n1
67507Cdk2cyclina Complexed With a Pyrazolopyridazine Inhibitor
67508Cdk2cyclina Complexed With a Pyrazolopyridazine Inhibitor
67795Cdk2cyclina Complexed With a Imidazo Triazin-2-amine
69433Cdk-2 With Indazole Inhibitor 17 Bound at ITS Active Site
69434Cdk-2 With Indazole Inhibitor 9 Bound at ITS Active Site
69436Cdk-2-cyclin Complex With Indazole Inhibitor 9 Bound at ITS Active Site
70716Crystal Structure of a Benzthiophene Inhibitor Bound to Human Cyclin-dependent Kinase-2 (Cdk-2)
76611Novel Cdk-5 Inhibitors - Crystal Structure of Inhibitor EFP With Cdk-2
76612Novel Cdk-5 Inhibitors - Crystal Structure of Inhibitor EFQ With Cdk-2
86234The Structure of Cyclin Dependent Kinase 2 (Ckd2) With a Pyrazolobenzodiazepine Inhibitor
80523Crystal Structure of Cdk2 With Sar57, an Aminoindazole Type Inhibitor
80524Crystal Structure of Cdk2 With Sar60, an Aminoindazole Type Inhibitor
80525Crystal Structure of Cdk2 With Sar37, an Aminoindazole Type Inhibitor
85224Cdk2cyclina in Complex With DRB
87178Crystal Structure of Cdk2 in Complex With Inhibitor Bs-194
89696Structure of Cdk2 in Complex With a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine
88696Cdk2 in Complex With Two Molecules of 8-anilino-1-naphthalene Sulfonate
88698Cdk2 in Complex With 3 Molecules of 8-anilino-1-naphthalene Sulfonate
88699APO Cdk2 Crystallized From Jeffamine
88700Cdk2 in Complex With Inhibitor Jws648
88701Cdk2 Ternary Complex With Jws648 and ANS
88702Cdk2 in Complex With Inhibitor Su9516
88703Cdk2 Ternary Complex With Su9516 and ANS
90830Structure of a Pcdk2cyclina Transition-state Mimic
90831Structure of a Pcdk2cyclina Transition-state Mimic